AMAT
49
-6
EXPD
37
-5
KEY
75
-3
KSS
52
-4
PNW
60
-4
TMO
54
-2
LB
42
-6
ALLE
46
-7
HRL
35
12
GE
72
5
MAC
68
-2
MMC
60
2
COF
65
-3
AES
55
-3
CMA
73
-4
DHR
66
-4
M
59
-2
AIZ
59
-2
FMC
16
-13
MAS
60
-2
AMAT
49
-6
EXPD
37
-5
KEY
75
-3
KSS
52
-4
PNW
60
-4
TMO
54
-2
LB
42
-6
ALLE
46
-7
HRL
35
12
GE
72
5
MAC
68
-2
MMC
60
2
COF
65
-3
AES
55
-3
CMA
73
-4
DHR
66
-4
M
59
-2
AIZ
59
-2
FMC
16
-13
MAS
60
-2
Financhill
Back

Landis+Gyr Group AG Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell
25

LGYRF
Landis+Gyr Group AG

Last Price:
$61.32
Seasonality Move:
-0.53%
Buy
67

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$113.68
Seasonality Move:
-9.01%
Sell
25
Landis+Gyr Group AG (LGYRF) is a Sell

Is Landis+Gyr Group AG a Buy, Sell or Hold?

  • The current Landis+Gyr Group AG [LGYRF] share price is $61.32. The Score for LGYRF is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • LGYRF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LGYRF Stock Price Chart

What is Landis+Gyr Group AG's stock price today?

  • The Landis+Gyr Group AG share price today is $61.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGYRF is experiencing slight buying pressure.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $113.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

LGYRF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.78 Sell
Relative Strength Index (14 RSI): 3.81 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.18 - 76.26) Sell
Bollinger Bands (100): (60.57 - 77.85) Sell

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 59.45 Buy
Chaikin Money Flow: -357754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.81 - 108.61) Buy
Bollinger Bands (100): (93.91 - 107.83) Buy

LGYRF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.32 Sell
20-day SMA: 64.88 Sell
50-day SMA: 73.38 Sell
200-day SMA: 65.21 Sell
8-day EMA: 61.64 Sell
20-day EMA: 64.86 Sell
50-day EMA: 69.09 Sell
200-day EMA: 68.97 Sell

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.1 Buy
20-day SMA: 105.06 Buy
50-day SMA: 105.14 Buy
200-day SMA: 81.74 Buy
8-day EMA: 108.55 Buy
20-day EMA: 106.16 Buy
50-day EMA: 103.93 Buy
200-day EMA: 86.65 Buy

Landis+Gyr Group AG Earnings Growth & LGYRF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

Landis+Gyr Group AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):